MANILA, Philippines — Three more developers of COVID-19 vaccines have applied to conduct clinical trials in the country, the Department of Science and Technology (DOST) said Tuesday.
DOST Undersecretary Rowena Cristina Guevara said that the Task Group on Vaccine Evaluation and Selection has received clinical trial applications from the West China Hospital and Sichuan University, Shenzhen Kangtai Biological Products Co., and Eubiologics Co. Ltd.
“Evaluation of the first two new applications are ongoing, while Eubiologics Co. Ltd is still completing some requirements,” she said in an online media forum.
At present, the Food and Drug Administration (FDA) has already approved …
Keep on reading: DOST: 3 more COVID vaccine developers apply for local clinical trials